Literature DB >> 20386876

[Acute and long-term treatment for bipolar depression].

H Grunze1, S Dargel.   

Abstract

Bipolar depression is linked with substantial burden and a high suicide risk, making a rapid and highly efficacious treatment mandatory. However, similar to mania, aspects of long-term treatment should already be considered at treatment initiation. With comparable efficacy, drugs with a beneficial safety and tolerability profile should be preferred. Additional psychotherapy can also noticeably improve both short- and long-term outcome of bipolar depression. Electroconvulsive therapy (ECT) still has its place in severe, treatment-resistant bipolar depression. Whereas ECT is a domain of specialised centres, correct diagnosis and both pharmacological and psychotherapeutic treatment initiation are essential tasks of primary care practitioners and secondary care psychiatrists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386876     DOI: 10.1007/s00115-009-2851-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  39 in total

1.  Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression.

Authors:  M Bauer; E D London; N Rasgon; S M Berman; M A Frye; L L Altshuler; M A Mandelkern; J Bramen; B Voytek; R Woods; J C Mazziotta; P C Whybrow
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

2.  Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.

Authors:  Zhang-Jin Zhang; Wan-Hu Kang; Qing-Rong Tan; Qiang Li; Cheng-Ge Gao; Feng-Gang Zhang; Huai-Hai Wang; Xian-Cang Ma; Ce Chen; Wei Wang; Li Guo; Ya-Hong Zhang; Xiao-Bo Yang; Guang-De Yang
Journal:  J Psychiatr Res       Date:  2005-08-02       Impact factor: 4.791

Review 3.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

4.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

Authors:  Heinz Grunze; Eduard Vieta; Guy M Goodwin; Charles Bowden; Rasmus W Licht; Hans-Jürgen Möller; Siegfried Kasper
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

5.  Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

Authors:  K D Denicoff; E E Smith-Jackson; E R Disney; S O Ali; G S Leverich; R M Post
Journal:  J Clin Psychiatry       Date:  1997-11       Impact factor: 4.384

6.  Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.

Authors:  Andrew A Nierenberg; Michael J Ostacher; Joseph R Calabrese; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Sachiko Miyahara; Mark S Bauer; Michael E Thase; Stephen R Wisniewski; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

Review 7.  Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis.

Authors:  L A Smith; V R Cornelius; J M Azorin; G Perugi; E Vieta; A H Young; C L Bowden
Journal:  J Affect Disord       Date:  2009-11-18       Impact factor: 4.839

8.  A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.

Authors:  Francesco Colom; Eduard Vieta; Anabel Martinez-Aran; Maria Reinares; Jose Manuel Goikolea; Antonio Benabarre; Carla Torrent; Merce Comes; Barbara Corbella; Gemma Parramon; Josep Corominas
Journal:  Arch Gen Psychiatry       Date:  2003-04

9.  A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Authors:  Guy M Goodwin; Charles L Bowden; Joseph R Calabrese; Heinz Grunze; Siegfried Kasper; Robin White; Paul Greene; Robert Leadbetter
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

10.  Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.

Authors:  F Colom; E Vieta; J Sánchez-Moreno; R Palomino-Otiniano; M Reinares; J M Goikolea; A Benabarre; A Martínez-Arán
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more
  2 in total

1.  [A new evidence and consensus-based German guidelines for diagnosis and treatment of bipolar disorders].

Authors:  M Bauer
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

2.  Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study.

Authors:  Susanne Kraemer; Anette Minarzyk; Steffen Eppendorfer; Carsten Henneges; Hans-Peter Hundemer; Stefan Wilhelm; Heinz Grunze
Journal:  BMC Psychiatry       Date:  2013-07-17       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.